γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway
Molecular Carcinogenesis · 2024-10 · 63 (10) · 2013-2025
DOI: 10.1002/mc.23790 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 09.07.2024. Verfasst von Hao Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Forth Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Autophagy, Glycogen Synthase Kinase 3 beta, beta Catenin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Project of Research and Innovation of Harbin Medical University, National Natural Science Fund.
Abstract (Originalsprache)
γ‐Tocotrienol (γ‐T3) is a major subtype of vitamin E, mainly extracted from palm trees, barley, walnuts, and other plants. γ‐T3 has effects on anti‐inflammation, anti‐oxidation, and potential chemoprevention against malignancies. It is still uncompleted to understand the effect of γ‐T3 on the inhibitory mechanism of cancer. This study aimed to investigate whether γ‐T3 enhanced autophagy in gastric cancer and the underlying molecular mechanism. The results showed that γ‐T3 (0–90 μmol/L) inhibited the proliferation of gastric cancer MKN45 cells and AGS cells, and arrested the cell cycle at the G0/G1 phase in a dose‐dependent manner. Autophagy was increased in MKN45 cells treated with γ‐T3 (0–45 μmol/L), especially at a dose of 30 μmol/L for 24 h. These effects were reversed by 3‐methyladenine pretreatment. Furthermore, γ‐T3 (30 μmol/L) also significantly downregulated the expression of pGSK‐3β (ser9) and β‐catenin protein in MKN45 cells, and γ‐T3 (20 mg/kg b.w.) effectively decreased the growth of MKN45 cell xenografts in BABL/c mice. GSK‐3β inhibitor‐CHIR‐99021 reversed the negative regulation of GSK‐3β/β‐Catenin signaling and autophagy. Our findings indicated that γ‐T3 enhances autophagy in gastric cancer cells mediated by GSK‐3β/β‐Catenin signaling, which provides new insights into the role of γ‐T3 enhancing autophagy in gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The Forth Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Endoncrology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Cardiovascular Ultrasound, Harbin, China.
- College of Public Health, Harbin Medical University, Harbin, China.
- International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Hao Zhu, Jia-Ren Liu
Förderung
- Project of Research and Innovation of Harbin Medical University
- National Natural Science Fund
Zitieren
APA
Zhu, H., Wang, F. L., Zhang, S., Xue, L., Gao, G. Q., Dong, H. W., Wang, Q., Sun, W. G., & Liu, J. R. (2024). γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway. Molecular Carcinogenesis, 63(10), 2013-2025. https://doi.org/10.1002/mc.23790
Vancouver
Zhu H, Wang FL, Zhang S, Xue L, Gao GQ, Dong HW, et al. γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway. Molecular Carcinogenesis. 2024;63(10):2013-2025. doi:10.1002/mc.23790
BibTeX
@article{Zhu2024,
author = {Zhu, Hao and Wang, Fa-Lin and Zhang, Shuang and Xue, Li and Gao, Guang-Qiang and Dong, Hong-Wei and Wang, Qi and Sun, Wen-Guang and Liu, Jia-Ren},
title = {γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway},
journal = {Molecular Carcinogenesis},
year = {2024},
volume = {63},
number = {10},
pages = {2013--2025},
doi = {10.1002/mc.23790}
}
EUVIMED